|
Market Cap (6-Jul) $43,777,552 (0th) |
Close (30-Jun) $0.300 |
Volume (30-Jun) 160,000 |
Shortsold (19-Jun) 3,649,691 (0.81%) (242nd) |
|
52w High $0.325 |
52w Low $0.082 |
P/E - |
EPS -0.03 |
MAP released this announcement to the ASX on 8 June 2022, 9:08. The announcement is marked as price sensitive, and is 2 page(s) in length and 195.88kb in size.
You can view all announcements from MAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, MAP was 0.000% short sold according to ASIC data. It was ranked the 698th most shorted stock on the ASX. It is now ranked as the 242nd most shorted stock on the ASX with 0.815% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MAP | |
|---|---|
| Notification of cessation of securities - MAP | 30 June 2023, 17:06 |
| Microba Commences Phase I Clinical Trial for IBD Therapeutic | 28 June 2023, 9:04 |
| MRFF Grant Awarded to QUT, In Collaboration With Microba | 27 June 2023, 11:17 |
| Microba & Ginkgo Commence Therapeutics Program | 8 June 2022, 9:08 |
| Release of Restricted Securities from Escrow | 6 June 2022, 18:01 |
| Microba Appoints CRO for IBD Clinical Trial | 27 May 2022, 9:13 |
| Partnership signed with nib-backed Midnight Health | 26 May 2022, 9:05 |
You must be logged in to post a reply.
